Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and <i>in silico</i> studies

Abdullah Alkhammash, Basima A. A. Saleem, Khulood H. Oudah, Mohamed Ahmed, Kasim Sakran Abass, Sara Mahmoud Farhan, Magdi E. A. Zaki, Sobhi M. Gomha

Open source

DOI
10.1039/d6ra07867b
Published
2026
Container
RSC Advances
Publisher
Royal Society of Chemistry (RSC)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6ra07867b,
  title = {Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and
                    <i>in silico</i>
                    studies},
  author = {Abdullah Alkhammash and Basima A. A. Saleem and Khulood H. Oudah and Mohamed Ahmed and Kasim Sakran Abass and Sara Mahmoud Farhan and Magdi E. A. Zaki and Sobhi M. Gomha},
  year = {2026},
  journal = {RSC Advances},
  doi = {10.1039/d6ra07867b},
  url = {https://doi.org/10.1039/d6ra07867b}
}

RIS

TY  - JOUR
TI  - Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and
                    <i>in silico</i>
                    studies
AU  - Abdullah Alkhammash
AU  - Basima A. A. Saleem
AU  - Khulood H. Oudah
AU  - Mohamed Ahmed
AU  - Kasim Sakran Abass
AU  - Sara Mahmoud Farhan
AU  - Magdi E. A. Zaki
AU  - Sobhi M. Gomha
PY  - 2026
JO  - RSC Advances
DO  - 10.1039/d6ra07867b
UR  - https://doi.org/10.1039/d6ra07867b
ER  - 

APA

Alkhammash, A., Saleem, B. A. A., Oudah, K. H., Ahmed, M., Abass, K. S., Farhan, S. M., Zaki, M. E. A., & Gomha, S. M. (2026). Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and <i>in silico</i> studies. RSC Advances. https://doi.org/10.1039/d6ra07867b

Source records